Why Covaxin may have an edge against new virus variants

The chairman and managing director of Bharat Biotech, Dr Kishna Ella, said its Covid-19 vaccine, Covaxin, would be effective on mutant strains of the coronavirus, and therefore is justified to receive the emergency approval despite a lack of data on its efficacy and an incomplete Phase 3 trial.